More answers like this
GPT-5Oct 1, 2026openai/gpt-5-2025-08-07
Should AI development be paused or restricted?
Short answer: Don’t freeze all AI, but do slow or pause specific frontier scaling and tightly restrict high‑risk uses until they clear robust safety bars.
How to think about it
•Blanket pause: Overbroad. It would stall useful progress (medicine, accessibility, education), entrench incumbents, and just move development offshore.
•No restrictions: Under-protects against real risks (bio, cyber, critical infrastructure, elections, at‑scale manipulation).
•Middle path: Risk-based governance with conditional pauses when evidence shows unacceptable hazards.
When a pause is warranted
•Conditional moratoriums on training/deploying frontier models if independent evaluations show any of the following and mitigations aren’t yet reliable:
•Material assistance to biological or chemical weapon design or acquisition.
•Offensive cyber capability that enables non‑experts to conduct intrusions or scale zero‑day exploitation.
•Persuasive manipulation at population scale (e.g., targeted, tailored disinfo with high conversion).
•Autonomous long‑horizon task execution with signs of uncontrolled replication or resource acquisition.
•Systemic jailbreak susceptibility that can’t be fixed without major retraining.
•Pauses should be narrowly scoped, time‑bounded (e.g., 6–12 months), and lifted once benchmarks are passed and controls verified by independent auditors.
Where restrictions make sense now
•High‑risk domains: healthcare, finance, critical infrastructure, legal decisions, hiring, education testing, elections, law enforcement, and synthetic biology.
•Require certification before deployment; meaningful human oversight; auditable logs; rollback/“recall” ability; and incident reporting.
Concrete mechanisms that balance progress and safety
1)Capability eval gates
•Standardized red‑teaming and third‑party audits (bio, cyber, persuasion, autonomy).
•Pass–fail gates before scaling parameters/data/compute beyond set thresholds.
2)Compute and scaling governance
•Licensing for training runs above defined FLOP thresholds.
•Pre‑training notifications, secure compute, and basic telemetry on high‑end chips.
•Sunset clauses and periodic review so rules track tech progress.
3)Responsible release and access control
•Staged releases; rate limits; tool-use restrictions (especially code execution, chemistry/biology toolchains).
•Identity or KYC checks for powerful dual‑use features; tiered access and geographic risk controls.
4)Information‑hazard controls
•Block capabilities and content that materially lower barriers to real‑world harm (e.g., pathogen design, weaponization).
•Secure plugins/APIs; require safety interlocks for autonomous agents.
5)Transparency and provenance
•Public system cards, training‑data provenance practices, and post‑deployment monitoring summaries.
•Content provenance/watermarking for AI-generated media; support C2PA‑style standards.
6)Accountability and liability
•Duty-of-care standards tied to foreseeable misuse.
•Independent audits, compliance programs, and penalties for negligent deployment.
•Incident reporting to a competent authority; empower “model recalls.”
7)Support the good stuff
•Fund safety research, evaluations, and interpretability.
•Encourage privacy‑preserving and domain‑bounded models.
•Promote open science on safety methods while restricting dangerous capability artifacts.
Trade‑offs to keep in view
•Innovation vs. risk: Use proportional, evidence‑based thresholds; avoid rules that only big players can satisfy.
•National security vs. openness: Coordinate internationally; align export controls with safety—not with protectionism.
•Flexibility: Build in review cycles and sunset clauses so rules evolve as techniques improve.
Bottom line
•Don’t stop all AI. Do enforce strong restrictions in high‑risk uses and require models to clear independent safety gates before further scaling. Use targeted, reversible pauses when concrete evaluations show unacceptable danger and lift them once controls demonstrably work.